BellRing Brands posted higher revenues in Q3 2025, driven by volume and pricing gains. However, a legal settlement provision significantly lowered GAAP earnings. Adjusted earnings remained strong, supported by increased household penetration and innovation across the portfolio.
Premier Protein sales increased 6.0% year-over-year in the quarter.
Volume grew 3.5% and price/mix improved 2.7%, boosting net sales.
Net income declined due to a $68.1M legal provision related to Joint Juice litigation.
Adjusted EBITDA rose slightly to $120.3M, while adjusted EPS increased to $0.55.
BellRing narrowed its FY25 outlook while maintaining growth expectations. Adjusted EBITDA and revenue targets remain strong despite minor shipment shifts.